Cobenfy (xanomeline/trospium) Patient Assistance Program
Don’t let the high cost of brand novel schizophrenia therapy disrupt your mental health treatment. We help eligible patients access Cobenfy (xanomeline and trospium chloride capsules) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Cobenfy (xanomeline/trospium) is FDA-approved for treatment of schizophrenia in adults. First-in-class muscarinic M1/M4 receptor agonist mechanism — a fundamentally different approach from traditional dopamine receptor antagonist antipsychotics. Trospium (peripheral anticholinergic) is added to reduce peripheral muscarinic side effects.
- Without assistance, Cobenfy costs commonly run approximately $1,900–$2,300 per month.
- Through AffordMyPrescriptions, qualifying patients can access Cobenfy for a flat $69.95 per month.
- Traditional antipsychotics: many generic (risperidone, olanzapine, quetiapine, aripiprazole, ziprasidone, paliperidone oral, haloperidol — first-line; each with different metabolic, EPS, prolactin, and sedation profiles). Long-acting injectables: Abilify Maintena, Aristada, Invega Sustenna/Trinza/Hafyera, Risperdal Consta, Zyprexa Relprevv, Uzedy. Cobenfy provides a mechanism-based option without dopamine blockade — no EPS, no prolactin elevation, minimal metabolic effects. Psychiatrist prescribing.
What is Cobenfy Prescription Assistance Program?
The Cobenfy Patient Assistance Program helps eligible patients access Cobenfy for schizophrenia at little or no cost when meeting income, insurance, and clinical criteria. Free to apply but requires detailed applications, psychiatrist coordination, and ongoing renewal.
At AffordMyPrescriptions, our Patient Advocates handle the entire Cobenfy PAP enrollment for a flat $69.95 per month — so you never face a gap in your Cobenfy schizophrenia therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Cobenfy enrollment — so you never face a gap in your schizophrenia treatment.
Pharmacy Price Comparison
- Without assistance, Cobenfy costs thousands of dollars per month at retail pharmacies. A Patient Assistance Program can offset costs if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Generic aripiprazole (alt) | ~$25/mo | Traditional generic alt |
| Walgreens | ~$2,200/mo | Save substantially |
| CVS Pharmacy | ~$2,300/mo | Save substantially |
| Walmart | ~$1,900/mo | Save substantially |
| Specialty pharmacy | ~$1,900/mo | Save substantially |
| Generic risperidone/olanzapine | ~$20/mo | Traditional generic alt |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Cobenfy — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Cobenfy Prescription Program?
The Cobenfy Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Traditional antipsychotics are widely available generic and cheap — Cobenfy offers a novel mechanism appropriate for patients intolerant to or inadequately responsive to standard therapy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Cobenfy assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Cobenfy is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Cobenfy:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $1,900–$2,300 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Cobenfy assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Cobenfy Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Cobenfy:
Cobenfy is the first schizophrenia therapy targeting muscarinic (rather than dopamine) receptors — xanomeline activates M1/M4 receptors. Trospium is added as a peripheral anticholinergic to reduce peripheral muscarinic side effects. A novel approach without EPS, prolactin elevation, or major metabolic effects.
How It Works:
Schizophrenia is a chronic psychiatric disorder with positive symptoms (hallucinations, delusions), negative symptoms (blunted affect, avolition), and cognitive symptoms. Traditional antipsychotics all block dopamine D2 receptors — effective for positive symptoms but with side effects (EPS, tardive dyskinesia, prolactin elevation, and metabolic effects varying by drug). Xanomeline activates M1 and M4 muscarinic acetylcholine receptors — indirectly modulating dopamine and other neurotransmitter systems. It improves positive and negative symptoms of schizophrenia in trials. Peripheral muscarinic side effects (GI, sweating, bradycardia) were historically limiting; trospium (a peripheral anticholinergic) is added to counteract these. A fundamentally different approach — no dopamine blockade.
Form and Use:
Cobenfy capsules containing xanomeline + trospium chloride. Twice-daily oral dosing with titration. Take fasting (or per current prescribing information). Common side effects are mostly GI (nausea, dyspepsia, constipation, vomiting) and dizziness/hypertension.
Generic Availability:
No generic Cobenfy. Traditional antipsychotics: many generic (risperidone, olanzapine, quetiapine, aripiprazole, ziprasidone, paliperidone oral, haloperidol, and older typicals — first-line for schizophrenia; each with distinct side effect profiles). Long-acting injectables: Abilify Maintena, Aristada, Invega Sustenna/Trinza/Hafyera, Risperdal Consta, Zyprexa Relprevv, Uzedy. Clozapine (generic) for treatment-resistant schizophrenia (requires ANC monitoring). Cobenfy uniquely lacks dopamine blockade — no EPS, no tardive dyskinesia, no prolactin elevation, minimal metabolic effects. NAMI and the Schizophrenia and Related Disorders Alliance provide patient support.
Warnings:
Cardiovascular effects (hypertension, tachycardia — monitor), gastrointestinal effects (nausea, dyspepsia, constipation, vomiting — dose titration and taking with food may help), urinary retention (anticholinergic — caution in men with prostatic issues; contraindicated in narrow-angle glaucoma), hepatotoxicity (monitor LFTs). Other: dizziness, headache. Drug interactions: multiple CYP interactions and additive anticholinergic effects with other agents. Psychiatric follow-up essential. Not for use in patients with severe hepatic impairment, urinary retention, or narrow-angle glaucoma.
FAQ (Frequently Asked Questions)
How much does Cobenfy cost without insurance?
$1,900–$2,300 per month at retail pharmacy. Generic traditional antipsychotics (risperidone, olanzapine, aripiprazole, quetiapine) cost $20–$50 per month with GoodRx — vastly cheaper for equivalent efficacy in many patients.
How is Cobenfy different from traditional antipsychotics?
Traditional antipsychotics block dopamine D2 receptors — effective for positive symptoms but causing EPS (tremor, rigidity, akathisia), tardive dyskinesia risk, prolactin elevation, and often metabolic effects (weight gain, diabetes, dyslipidemia). Cobenfy targets muscarinic M1/M4 receptors — a different mechanism without dopamine blockade — no EPS, no prolactin issues, minimal metabolic effects.
Can Cobenfy be used first-line for schizophrenia?
Cobenfy is FDA-approved for schizophrenia. Traditional generic antipsychotics remain first-line by cost and familiarity for most patients. Cobenfy is particularly valuable for patients with intolerance to metabolic effects, prolactin issues, or EPS from traditional agents. Discuss with your psychiatrist.
What are common Cobenfy side effects?
Gastrointestinal side effects are most common: nausea, dyspepsia, constipation, vomiting. Cardiovascular: hypertension, tachycardia. Others: dizziness, urinary retention (anticholinergic). Dose titration helps tolerability. Not for narrow-angle glaucoma or urinary retention.
Does Cobenfy affect metabolism/weight?
Cobenfy does not cause the metabolic side effects (weight gain, diabetes, dyslipidemia) associated with olanzapine, clozapine, quetiapine, and other atypical antipsychotics — a major advantage for patients concerned about metabolic effects.
Take Control of Your Medication Costs
Novel schizophrenia therapy without dopamine blockade — transformative for the right patient. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.